Early Phase 1 Multiple Sclerosis Trial, Not Yet Recruiting NCT07643974 Sponsor: Medstar Health Research Institute Condition: Multiple Sclerosis
Back to Multiple Sclerosis

Early Phase 1 Multiple Sclerosis Trial, Not Yet Recruiting

NCT07643974
Not Yet Recruiting Early Phase 1

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People who have a neurological diagnosis (a condition affecting the brain, spinal cord, or nerves).
  • People who are 18 years of age or older.
  • People who have had a bladder condition caused by their neurological diagnosis for at least 6 months.
  • People who do not have certain specific types of bladder symptoms (confirm with trial site for details on symptom categories).
  • People who do not currently have a urinary tract infection (confirmed within 24 hours before starting the trial treatment).
  • People who are living in the community and are not currently admitted to a hospital.

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People who have known urinary or genital health problems beyond their neurological bladder condition, such as kidney stones, bladder stones, or urine flowing back toward the kidneys.
  • People who have used preventative antibiotics or any antibiotics within 2 weeks before starting the trial treatment.
  • People who are currently using any substances put directly into the bladder, other than a saline (saltwater) rinse.
  • People who have a condition that weakens their immune system.
  • People who have a psychological or psychiatric condition that may affect their ability to follow instructions.
  • People who have an allergy to ampicillin, daptomycin, gentamicin, or probiotics.
  • People who are currently taking part in another research study that could affect the results of this trial.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 31 July 2026
Early Phase 1 studies are small, early exploratory studies that come before the main Phase 1 to 3 testing, so a standard phase success rate does not apply.

Contact this trial

Principal Investigator: Amanda Garver, DO, MedStar National Rehabilitation Hospital

Phone: 202-877-1000

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Not Yet Recruiting
Phase
Early Phase 1
Sponsor
Medstar Health Research Institute
Registry
ClinicalTrials.gov
Start date
1 June 2026
Est. completion
1 September 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Level of Lactobacillus rhamnosus GG in Urine

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 31 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov